ATE348626T1 - Milchsäurebakterium zur prävention der bauchfellentzündung - Google Patents

Milchsäurebakterium zur prävention der bauchfellentzündung

Info

Publication number
ATE348626T1
ATE348626T1 AT01936125T AT01936125T ATE348626T1 AT E348626 T1 ATE348626 T1 AT E348626T1 AT 01936125 T AT01936125 T AT 01936125T AT 01936125 T AT01936125 T AT 01936125T AT E348626 T1 ATE348626 T1 AT E348626T1
Authority
AT
Austria
Prior art keywords
perimonitis
prevention
lactic acid
acid bacteria
bacteria
Prior art date
Application number
AT01936125T
Other languages
English (en)
Inventor
Eduardo Schiffrin
Carlos Guarner
German Soriano
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Application granted granted Critical
Publication of ATE348626T1 publication Critical patent/ATE348626T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065—Microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/151—Johnsonii
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Dairy Products (AREA)
  • Confectionery (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
AT01936125T 2000-03-24 2001-03-22 Milchsäurebakterium zur prävention der bauchfellentzündung ATE348626T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00106441 2000-03-24

Publications (1)

Publication Number Publication Date
ATE348626T1 true ATE348626T1 (de) 2007-01-15

Family

ID=8168228

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01936125T ATE348626T1 (de) 2000-03-24 2001-03-22 Milchsäurebakterium zur prävention der bauchfellentzündung

Country Status (22)

Country Link
US (2) US7217414B2 (de)
EP (1) EP1276488B1 (de)
JP (1) JP2003527432A (de)
KR (1) KR20020087418A (de)
CN (1) CN1183916C (de)
AR (1) AR028288A1 (de)
AT (1) ATE348626T1 (de)
AU (1) AU783439C (de)
BG (1) BG107096A (de)
BR (1) BR0109496A (de)
CA (1) CA2403491A1 (de)
DE (1) DE60125345T2 (de)
ES (1) ES2276793T3 (de)
HK (1) HK1052465B (de)
HU (1) HUP0301059A3 (de)
IL (2) IL151596A0 (de)
MX (1) MXPA02009342A (de)
NO (1) NO20024488D0 (de)
PL (1) PL358214A1 (de)
UA (1) UA76104C2 (de)
WO (1) WO2001070246A1 (de)
ZA (1) ZA200208592B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2436264C (en) * 2001-02-06 2014-01-28 Societe Des Produits Nestle S.A. Endotoxin binding by lactic acid bacteria and bifidobacteria
RU2302747C2 (ru) * 2001-02-19 2007-07-20 Сосьете Де Продюи Нестле С.А. Продукт питания из злаков, содержащий пробиотический микроорганизм, продукт питания из злаков, содержащий метаболиты, продуцированные пробиотическими микроорганизмами, и способы их получения
ATE325604T1 (de) * 2002-02-21 2006-06-15 Nestle Sa Oral verabreichbare zusammensetzung zum schutz der haut vor licht
JP2005525348A (ja) * 2002-02-21 2005-08-25 ソシエテ デ プロデユイ ネツスル ソシエテ アノニム 皮膚のための光防護性の経口投与可能な組成物
EP1478242B1 (de) * 2002-02-21 2014-04-30 Societe Des Produits Nestle S.A. Futtermittel für haustiere zum schutz der haut gegen licht
EP1384483A1 (de) * 2002-07-23 2004-01-28 Nestec S.A. Probiotische Mikroorganismen zur Behandlung von Colon Irritabile durch die Verbesserung der neuromuskulären Darmfunktion
EP1931363B1 (de) 2005-09-28 2015-11-18 Nordisk Rebalance A/S Behandlung von entzündlicher darmerkrankung mit probiotischen bakterien und fermentierten cerealien als behandlungseffektoren
EP1992351B1 (de) * 2007-05-18 2016-05-11 Nestec S.A. Lactobacillus johnsonii zur vorbeugung von postoperativer Infektion
ES2378839T3 (es) * 2008-05-16 2012-04-18 Nestec S.A. Lactobacillus paracasei y control del peso
US8784798B2 (en) * 2009-05-11 2014-07-22 Nestec S.A. Bifidobacterium longum NCC2705 (CNCM I-2618) and immune disorders
GB0914878D0 (en) 2009-08-26 2009-09-30 Plant Bioscience Ltd Competetive exclusion compositions and methods
CN105816484A (zh) * 2015-01-07 2016-08-03 东宇生物科技股份有限公司 用于腹膜透析病患预防腹膜炎并减少肾功能恶化的组合物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1723116A1 (ru) * 1988-04-15 1992-03-30 Оренбургский Государственный Медицинский Институт Штамм бактерий BacILLUS SUвтILIS, используемый дл получени препарата дл профилактики и лечени воспалительных процессов и аллергических заболеваний
JPH04264034A (ja) 1991-02-18 1992-09-18 Snow Brand Milk Prod Co Ltd 生体内過酸化脂質抑制剤
US5716615A (en) * 1992-02-10 1998-02-10 Renata Maria Anna Cavaliere Vesely Dietary and pharmaceutical compositions containing lyophilized lactic bacteria, their preparation and use
DE69219768T2 (de) * 1992-07-06 1997-08-28 Societe Des Produits Nestle S.A., Vevey Milchbakterien
JP2712000B2 (ja) 1994-12-22 1998-02-10 ニチニチ製薬株式会社 Ｃ型肝炎治療剤
SE9501719D0 (sv) 1995-05-09 1995-05-09 Probi Ab Pharmaceutical composition
US6562629B1 (en) * 1999-08-11 2003-05-13 Cedars-Sinai Medical Center Method of diagnosing irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth by detecting the presence of anti-saccharomyces cerivisiae antibodies (asca) in human serum
JPH09301877A (ja) 1996-05-13 1997-11-25 Youshindou:Kk 肝炎治療・予防剤
IL128791A (en) * 1996-09-06 2001-10-31 Nestle Sa Ice cream
ATE206873T1 (de) * 1997-01-09 2001-11-15 Nestle Sa Probiotik enthaltendes getreideprodukt
IT1289984B1 (it) 1997-02-27 1998-10-19 Proge Farm Srl Ceppi di lattobacilli utili nel trattamento di disfunzioni del sistema gastrointestinale
CA2294165C (en) * 1997-07-05 2007-11-27 Societe Des Produits Nestle S.A. Frozen dessert
RO112995B1 (ro) * 1997-08-05 1998-03-30 Rodica Teodorescu Produs medicamentos pentru terapia colonului
US6368591B2 (en) * 1998-05-15 2002-04-09 Shanghai Sine Pharmaceutical Corporation Ltd. Beneficial microbe composition, new protective materials for the microbes, method to prepare the same and uses thereof

Also Published As

Publication number Publication date
DE60125345T2 (de) 2007-09-27
HUP0301059A3 (en) 2004-10-28
US7217414B2 (en) 2007-05-15
ES2276793T3 (es) 2007-07-01
HK1052465B (en) 2007-05-11
EP1276488B1 (de) 2006-12-20
MXPA02009342A (es) 2003-09-22
US20030044397A1 (en) 2003-03-06
ZA200208592B (en) 2004-02-10
HK1052465A1 (en) 2003-09-19
CN1183916C (zh) 2005-01-12
EP1276488A1 (de) 2003-01-22
NO20024488L (no) 2002-09-19
DE60125345D1 (de) 2007-02-01
AU6212701A (en) 2001-10-03
US7678370B2 (en) 2010-03-16
PL358214A1 (en) 2004-08-09
KR20020087418A (ko) 2002-11-22
CN1419454A (zh) 2003-05-21
WO2001070246A1 (en) 2001-09-27
NO20024488D0 (no) 2002-09-19
BR0109496A (pt) 2002-12-10
AU783439C (en) 2006-12-14
JP2003527432A (ja) 2003-09-16
AR028288A1 (es) 2003-04-30
IL151596A (en) 2008-07-08
BG107096A (bg) 2003-05-30
HUP0301059A2 (hu) 2003-07-28
UA76104C2 (en) 2006-07-17
CA2403491A1 (en) 2001-09-27
IL151596A0 (en) 2003-04-10
US20070172512A1 (en) 2007-07-26
AU783439B2 (en) 2005-10-27

Similar Documents

Publication Publication Date Title
DE60113496D1 (de) Verwendung von Glycyrrhizin zur Behandlung von Mastitis.
EP1233780A4 (de) Identifizierung des sortasegens
DE60019556D1 (de) 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
DE60124302D1 (de) Thiazolderivate zur behandlung von ppar-lierte krankheiten
DE60019555D1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
DE60134410D1 (de) Methode zur herstellung funktioneller proteindomänen
AR028253A1 (es) Inhibidores de la glucogeno fosforilasa
ATE275145T1 (de) Chinazolinderivate zur behandlung von tumoren
PL358451A1 (pl) Sposób sterylizacji materiałów biologicznych
DE60103137D1 (de) Impstoff zur behandlung von atherosclerosis
ATE538096T1 (de) Pyridinon-derivate zur behandlung von arteriosklerose
EP1274444A4 (de) Arzneistoffe zur behandlung psychiatrischer oder abusus-bedingter störungen
ATE512594T1 (de) Verbesserung des zustandes älterer haustiere
DE10082139T1 (de) Zusammensetzung zur Behandlung von Reibungspaaren
DE60136477D1 (de) Retinoide zur behandlung von emphysem
NO20034311D0 (no) CCR5-antagonister for behandling av AIDS
DE60218451D1 (de) 15-keto-prostaglandine zur behandlung arzneimittelinduzierter obstipation
ATE348626T1 (de) Milchsäurebakterium zur prävention der bauchfellentzündung
DE60100858D1 (de) Prozess zur herstellung der kristallinen form i von cabergolin
DE60328494D1 (de) Verbessertes system zur behandlung der stressbedingten harninkontinenz
DE60127538D1 (de) Verfahren zur herstellung von methionin
DE60204562D1 (de) Kaltwalzvorrichtung zur herstellung von ringförmigen teilen
DE60033117D1 (de) Verhinderung des Festklebens von Hartkonfekten
DE60021252D1 (de) Antikonvulsiva zur behandlung von autismus
DE60113157T2 (de) Verbessertes verfahren zur herstellung von simvastatin

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties